Finished product reference
Nicorandil
Tablet · Oral · 10 mg
- List code
- 6459
- Pharmacologic class
- Antianginal; potassium-channel activator with nitrate activity
What it is and how it works
Nicorandil opens ATP-sensitive potassium channels in vascular smooth muscle, causing arterial dilatation, and its nitrate moiety relaxes venous smooth muscle via cyclic GMP, reducing both afterload and preload and dilating coronary arteries.
Indications
Prevention and long-term treatment of stable angina pectoris in adults inadequately controlled by or intolerant of first-line antianginal drugs (beta-blockers or calcium-channel blockers).
Dosage and administration (summary)
Oral: initially 10 mg twice daily (5 mg twice daily if prone to headache), usually 10–20 mg twice daily, up to 30 mg twice daily.
Contraindications
Cardiogenic shock, hypotension, left ventricular failure with low filling pressures, hypovolaemia, acute pulmonary oedema, and concomitant use of phosphodiesterase-5 inhibitors or riociguat.
Warnings and precautions
Can cause serious ulceration of the mouth, gastrointestinal tract (including anal and perianal), skin and eye; treatment should be withdrawn if ulceration occurs. Headache is common at the start of treatment. Hyperkalaemia has been reported, particularly in renal impairment.
Pregnancy
Avoid unless essential because data are limited.
Storage and supply
Store below 25 °C in the original blister to protect from moisture.
Source: reference summary prepared from the EU SmPC/EPAR, BNF and WHO Model Formulary. The approved product information in Iran governs.
Other presentations of the same active ingredient
Reference information for professional sourcing and registration enquiries, not medical advice or a promotion. Drug information is condensed from US FDA prescribing information (public domain, via openFDA and DailyMed) and does not replace the product’s approved labelling in Iran. Availability, origin and documentation are confirmed per enquiry.
Tell us the quantity, the market and the timing.
Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.